HomeEXPRS2 • STO
add
ExpreS2ion Biotech Holding AB
Previous close
kr 22.75
Year range
kr 15.74 - kr 66.56
Market cap
60.48M SEK
Avg Volume
27.68K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.96M | 89.79% |
Operating expense | 15.06M | 2.32% |
Net income | -11.44M | 10.99% |
Net profit margin | -386.88 | 53.10% |
Earnings per share | — | — |
EBITDA | -12.27M | 10.98% |
Effective tax rate | 11.78% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 58.00M | -3.65% |
Total assets | 80.60M | -6.43% |
Total liabilities | 29.44M | -13.00% |
Total equity | 51.16M | — |
Shares outstanding | 2.66M | — |
Price to book | 1.18 | — |
Return on assets | -34.13% | — |
Return on capital | -52.99% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.44M | 10.99% |
Cash from operations | -20.35M | -2,482.55% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -23.54M | -1,003.15% |
Free cash flow | -18.53M | -361.64% |
About
Founded
2015
Website
Employees
18
